PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Lang, J.* ; Bergner, T.* ; Zinngrebe, J.* ; Lepelley, A.* ; Vill, K.* ; Leiz, S.* ; Wlaschek, M.* ; Wagner, M. ; Scharffetter-Kochanek, K.* ; Fischer-Posovszky, P.* ; Read, C.* ; Crow, Y.J.* ; Hirschenberger, M.* ; Sparrer, K.M.J.*

Distinct pathogenic mutations in ARF1 allow dissection of its dual role in cGAS-STING signalling.

EMBO Rep., DOI: 10.1038/s44319-025-00423-7 (2025)
Verlagsversion DOI PMC
Free journal
Creative Commons Lizenzvertrag
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Tight control of cGAS-STING-mediated DNA sensing is crucial to avoid auto-inflammation. The GTPase ADP-ribosylation factor 1 (ARF1) is crucial to maintain cGAS-STING homeostasis and various pathogenic ARF1 variants are associated with type I interferonopathies. Functional ARF1 inhibits STING activity by maintaining mitochondrial integrity and facilitating COPI-mediated retrograde STING trafficking and deactivation. Yet the factors governing the two distinct functions of ARF1 remained unexplored. Here, we dissect ARF1's dual role by a comparative analysis of disease-associated ARF1 variants and their impact on STING signalling. We identify a de novo heterozygous s.55 C > T/p.R19C ARF1 variant in a patient with type I interferonopathy symptoms. The GTPase-deficient variant ARF1 R19C selectively disrupts COPI binding and retrograde transport of STING, thereby prolonging innate immune activation without affecting mitochondrial integrity. Treatment of patient fibroblasts in vitro with the STING signalling inhibitors H-151 and amlexanox reduces chronic interferon signalling. Summarizing, our data reveal the molecular basis of a ARF1-associated type I interferonopathy allowing dissection of the two roles of ARF1, and suggest that pharmacological targeting of STING may alleviate ARF1-associated auto-inflammation.
Impact Factor
Scopus SNIP
Altmetric
6.200
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Arf1 ; Interferon ; Interferonopathy ; Sting ; Cgas; Cyclic Gmp-amp; Structural Basis; Ikk-epsilon; Recruitment; 2nd-messenger; Trafficking; Activation; Retrieval; Inhibitor; Mechanism
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 1469-221X
e-ISSN 1469-3178
Zeitschrift EMBO Reports
Verlag EMBO Press
Verlagsort Campus, 4 Crinan St, London, N1 9xw, England
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Neurogenomics (ING)
POF Topic(s) 30205 - Bioengineering and Digital Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-503200-001
Förderungen Medical Faculty, Ulm University
German Federal Ministry of Education and Research (BMBF)
German Research Foundation (DFG)
DFG/Agence Nationale de la Recherche (ANR, France)
Inserm
ANR (ANR)
European Research Council
UK Medical Research Council Human Genetics Unit core grant
Agence Nationale de la Recherche (France) under the Investissements d'avenir programme
Margarete von Wrangell-Habilitationsprogramm (Ministry of Science, Research and Arts Baden-Wuerttemberg, European Social Fund)
DFG
Deutsche Forschungsgemeinschaft (DFG)
DOI 10.1038/s44319-025-00423-7
WOS ID 001450800000001
Scopus ID 105000955899
PubMed ID 40128408
Erfassungsdatum 2025-05-09
[➜Korrektur melden]